Listen to The Lancet Oncology
Medical
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
Location:
United States
Description:
The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
Language:
English
Episodes
Choosing Wisely India
4/2/2019
CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India.
Duration:00:12:33
Paediatric vertebral radiotherapy
3/5/2019
Bianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients.
Duration:00:14:19
Malignant plural mesothelioma
2/2/2019
Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.
Duration:00:20:19
CAR T-cell therapy
1/3/2019
Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Duration:00:12:44
Cervical cancer screening in older women
11/29/2018
Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer.
Duration:00:12:00
Palliative care in oncology
10/19/2018
Stein Kaasa and Jon Loge discuss their new Commission on palliative care.
Duration:00:10:25
Global review of cancer control
9/27/2018
Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
Duration:00:10:34
Are patient reported outcomes consistent?
8/31/2018
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
Duration:00:08:04
Changing incidence of adolescent cancer
8/31/2018
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.
Duration:00:08:53
Diffuse intrinsic pontine glioma
8/14/2018
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.
Duration:00:22:08
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
6/30/2018
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.
Duration:00:09:49
Gender and cancer immunotherapy efficacy
6/1/2018
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.
Duration:00:09:37
PROs in regulatory decision making
4/25/2018
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
Duration:00:11:33
Vulvar field resection
3/29/2018
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.
Duration:00:13:53
Chromatin organisation and cancer prognosis
3/1/2018
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.
Duration:00:07:24
Trial design for brain metastases: The Lancet Oncology: Jan 2018
12/30/2017
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
Duration:00:11:11
Lung cancer screening: The Lancet Oncology: November 27, 2017
11/28/2017
John Field discusses a European position statement on lung cancer screening using low-dose CT.
Duration:00:10:29
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
11/1/2017
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.
Duration:00:10:45
Cancer in Peru: The Lancet Oncology
9/28/2017
Ben Anderson talks about cancer care and cancer trends in Peru.
Duration:00:19:09
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
9/2/2017
Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.
Duration:00:04:16